Elon Musk’s brain implant startup Neuralink has attracted lots of criticism and skepticism but it also seems to have generated a lot of optimism for the thousands of potential patients interested in human trials.
The company earlier this year got FDA approval to begin human trials and began recruiting shortly thereafter. According to a lengthy Bloomberg profile on Neuralink, the ambitions for human brain implants start slow with 11 surgeries planned for next year, but they expand to more than 22,000 a year by 2030.